[go: up one dir, main page]

AU3196100A - Heterocyclic sulfonamide derivatives - Google Patents

Heterocyclic sulfonamide derivatives

Info

Publication number
AU3196100A
AU3196100A AU31961/00A AU3196100A AU3196100A AU 3196100 A AU3196100 A AU 3196100A AU 31961/00 A AU31961/00 A AU 31961/00A AU 3196100 A AU3196100 A AU 3196100A AU 3196100 A AU3196100 A AU 3196100A
Authority
AU
Australia
Prior art keywords
sulfonamide derivatives
heterocyclic sulfonamide
heterocyclic
derivatives
sulfonamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31961/00A
Inventor
Yasuhiko Fujii
Yoshinori Tamura
Fumihiko Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU3196100A publication Critical patent/AU3196100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU31961/00A 1999-03-26 2000-03-21 Heterocyclic sulfonamide derivatives Abandoned AU3196100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8452699 1999-03-26
JP11/84526 1999-03-26
PCT/JP2000/001708 WO2000058304A1 (en) 1999-03-26 2000-03-21 Heterocyclic sulfonamide derivatives

Publications (1)

Publication Number Publication Date
AU3196100A true AU3196100A (en) 2000-10-16

Family

ID=13833094

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31961/00A Abandoned AU3196100A (en) 1999-03-26 2000-03-21 Heterocyclic sulfonamide derivatives

Country Status (2)

Country Link
AU (1) AU3196100A (en)
WO (1) WO2000058304A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0102935A3 (en) 1998-06-03 2002-01-28 Gpi Nil Holdings Inc Wilmingto N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres and pharmaceutical compositions containing them
KR100384693B1 (en) * 2000-04-07 2003-05-22 삼성전자주식회사 Sulfonamide Derivative as a Matrix Metalloproteinase Inhibitor
KR100372757B1 (en) * 2000-04-07 2003-02-17 삼성전자주식회사 Sulfonamide Derivative as a Matrix Metalloproteinase Inhibitor
KR100405912B1 (en) * 2000-04-08 2003-11-14 삼성전자주식회사 Sulfonamide Derivative as a Matrix Metalloproteinase Inhibitor
KR20040027920A (en) * 2001-08-20 2004-04-01 오노 야꾸힝 고교 가부시키가이샤 Remedial agent for cardiac failure
PE20030701A1 (en) 2001-12-20 2003-08-21 Schering Corp COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
EP1556037B1 (en) 2002-10-18 2006-11-02 F. Hoffmann-La Roche Ag 4-piperazinyl benzenesulfonyl indoles with 5-ht6 receptor affinity
KR20040041418A (en) * 2002-11-11 2004-05-17 재단법인 목암생명공학연구소 Angiogenesis inhibitor containing sulfonamide derivatives
DE10300015A1 (en) 2003-01-03 2004-07-15 Aventis Pharma Deutschland Gmbh Imino acid derivatives as inhibitors of matrix metal proteinases
US6992096B2 (en) 2003-04-11 2006-01-31 Ptc Therapeutics, Inc. 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
US7576222B2 (en) 2004-12-28 2009-08-18 Wyeth Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase
SG170819A1 (en) 2006-03-30 2011-05-30 Ptc Therapeutics Inc Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
US9873677B2 (en) 2014-03-06 2018-01-23 Ptc Therapeutics, Inc. Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
MX2018005361A (en) 2015-10-30 2018-06-07 Ptc Therapeutics Inc Methods for treating epilepsy.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4206045A1 (en) * 1992-02-27 1993-09-02 Bayer Ag SULFONYLBENZYL SUBSTITUTED PYRIDONE
DE4206043A1 (en) * 1992-02-27 1993-09-02 Bayer Ag SULFONYLBENZYL-SUBSTITUTED IMIDAZOLE
CN1232451A (en) * 1996-08-28 1999-10-20 普罗克特和甘保尔公司 Substituted cyclic amine metalloprotease inhibitors

Also Published As

Publication number Publication date
WO2000058304A1 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
AU5108000A (en) Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
AU6314900A (en) Biarylurea derivatives
AU6714700A (en) Cyclopropylindole derivatives
AU7314200A (en) Benzimidazole derivatives
AU5235599A (en) N-substituted sulfonamide derivatives
AUPQ309399A0 (en) Benzothiazoline derivatives
AU5429000A (en) Novel bicyclonucleoside derivatives
AU5235699A (en) Sulfonamide derivatives
AU3196100A (en) Heterocyclic sulfonamide derivatives
AU7952800A (en) 2-alkoxybenzene derivatives
AU3670000A (en) Novel thiazolobenzimidazole derivatives
AU2001280470A1 (en) Heterocyclic sulfonamide derivatives
AU2001282865A1 (en) Heterocyclic sulfonamide derivatives
AU2001241512A1 (en) Sulfonamide derivatives
AU5240099A (en) Heterocyclic sulphonamide derivatives
AU7963300A (en) Novel bipyridyl derivatives
AUPP921299A0 (en) New heterocyclic compounds
AU6262300A (en) Indolinylamide derivatives
AU7450300A (en) Sulfonamide derivatives
AU3196300A (en) Carbocyclic sulfonamide derivatives
AU5233699A (en) Sulfonamide derivatives
GB9929037D0 (en) Heterocyclic derivatives
AU1558300A (en) 1-cycloalkylpyrazoyl-benzoyl derivatives
AU7961800A (en) Thiazolidinedione derivatives
AU5666800A (en) Difuropyrone derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase